Literature DB >> 28467999

Stemness in Liver Cancer.

Snorri S Thorgeirsson1.   

Abstract

Cancer cells possessing "stemness," or stem-cell properties, are referred to as cancer stem cells (CSC) or cancer-initiating cells. The concept that these cells rest at the apex of the cancer hierarchy is an evolving theme in cancer research. These cells are by definition primarily responsible for the initiation and propagation of tumors as well as relapse after therapy, and they are therefore of major scientific interest. Several studies indicate that hepatocellular carcinomas that harbor phenotypic features of stem cells and progenitor cells constitute a subclass of therapeutically challenging cancers that are associated with a particularly poor prognosis. We recently demonstrated that any cell type in the mouse hepatic lineage can undergo oncogenic reprogramming into a CSC by activating different cell type-specific pathways [<citeref rid="ref1">1</citeref>]. Identification of common and cell of origin-specific phenotypic and genetic changes could provide new therapeutic targets for liver cancer.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Cancer; Cancer stem cells; Liver; Stemness

Mesh:

Year:  2017        PMID: 28467999      PMCID: PMC5841535          DOI: 10.1159/000456592

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  6 in total

Review 1.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?

Authors:  Vicki Plaks; Niwen Kong; Zena Werb
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

Review 2.  Functional and genetic deconstruction of the cellular origin in liver cancer.

Authors:  Jens U Marquardt; Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

3.  Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.

Authors:  Ágnes Holczbauer; Valentina M Factor; Jesper B Andersen; Jens U Marquardt; David E Kleiner; Chiara Raggi; Mitsuteru Kitade; Daekwan Seo; Hirofumi Akita; Marian E Durkin; Snorri S Thorgeirsson
Journal:  Gastroenterology       Date:  2013-03-19       Impact factor: 22.682

4.  Central role of c-Myc during malignant conversion in human hepatocarcinogenesis.

Authors:  Pal Kaposi-Novak; Louis Libbrecht; Hyun Goo Woo; Yun-Han Lee; Nathaniel C Sears; Cedric Coulouarn; Elizabeth A Conner; Valentina M Factor; Tania Roskams; Snorri S Thorgeirsson
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

Review 5.  Tumoral reprogramming: Plasticity takes a walk on the wild side.

Authors:  Elena Campos-Sánchez; César Cobaleda
Journal:  Biochim Biophys Acta       Date:  2014-07-17

Review 6.  Stem cell origin of cancer and differentiation therapy.

Authors:  Stewart Sell
Journal:  Crit Rev Oncol Hematol       Date:  2004-07       Impact factor: 6.312

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.